Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (34 ops.)
Latest filing published 05 Jan 2026 for Regeneron Pharmaceuticals, INC.. Read the official filing
Filing timeline
BuySaleGeorge Yancopoulos
Insider track record
Disclosed buys
0
Disclosed sells
34
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
George Yancopoulos: trading record in brief
George Yancopoulos (chief executive) discloses dealings in Regeneron Pharmaceuticals, Inc. to SEC (Form 4). We count 104 filings; the first trade dates from 2 November 2015 and the latest from 31 December 2025.
Every open-market trade on record is a sale: 34 sales worth €158.5M. Besides market trades, the filings include 13 share grants and 15 option exercises.
On 5 January 2026 came the latest disclosure, an option exercise in Regeneron Pharmaceuticals, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to George Yancopoulos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
28,570 shares0Common StockSEC:0001226690-26-000002:0
146,815 shares@ US$555.6729.6% of flowCommon StockSEC:0001226690-25-000005:0
75,799 shares0Common StockSEC:0001883850-24-000033:0
111 shares@ US$965.690.0% of flowCommon StockSEC:0001968202-24-000093:0
907 shares@ US$967.400.4% of flowCommon StockSEC:0001968202-24-000094:0
16,848 shares@ US$900.006.0% of flowCommon StockSEC:0001883850-24-000012:0
36,296 shares0Common StockSEC:0001883850-24-000013:0
172,723 shares@ US$399.6628.0% of flowCommon StockSEC:0001968202-24-000068:0
16,848 shares@ US$900.006.0% of flowCommon StockSEC:0001883850-24-000007:0
25,155 sharesCommon StockSEC:0001883850-23-000095:0
254 shares@ US$800.590.1% of flowCommon StockSEC:0001883850-23-000062:0
13,189 shares@ US$800.084.3% of flowCommon StockSEC:0001883850-23-000044:0
239,063 shares@ US$179.1317.0% of flowCommon StockSEC:0001883850-21-000034:0
773 shares@ US$625.000.2% of flowCommon StockSEC:0001708138-21-000055:0
50,000 shares@ US$600.0611.4% of flowCommon StockSEC:0001708138-21-000044:0
82,108 shares0Common StockSEC:0001708138-21-000026:0
16 of 16 declarations
